Position in TGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$152,055,019
+$131,035,596 QoQ
Shares Held
2,767,656
+337.4% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#8
of 426 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. TGTX ranks #35 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in TGTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $152,055,019 | 2,767,656 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,019,423 | 632,734 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,063,220 | 605,945 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,624,764 | 958,471 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $55,696,107 | 1,547,544 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,398,518 | 390,528 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,942,739 | 297,101 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,906,285 | 81,500 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,564,114 | 87,921 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,302,021 | 85,603 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,376,443 | 80,588 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $445,914 | 53,339 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,403,287 | 298,039 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,120,389 | 74,494 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,096,238 | 92,666 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $619,131 | 104,583 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $426,092 | 100,257 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,525,072 | 580,975 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,038,848 | 580,992 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $47,428,925 | 1,425,148 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $73,066,822 | 1,883,651 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $77,955,836 | 1,617,341 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $72,871,956 | 1,400,845 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,365,000 | 51,009 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||